|
ViiV Healthcare announces FDA priority review designation for dolutegravir
|
17 February 2013 |
|
GSK response to news article in The Guardian on UK legal proceedings related to Avandia
|
30 January 2013 |
|
GSK forms partnership with Vodafone to help increase childhood vaccination in Mozambique
|
11 December 2012 |
|
GSK welcomes the publication of the 2012 Access to Medicines Index
|
03 December 2012 |
|
GSK announces start of Phase lll programme for mepolizumab in severe refractory asthma
|
29 October 2012 |
|
Millions of children in Pakistan to be protected against pneumococcal disease with GSK's Synflorix
|
09 October 2012 |
|
GSK and Theravance announce completion of the Phase III programme for once-daily LAMA/LABA (UMEC/VI) in COPD
|
26 August 2012 |
|
GlaxoSmithKline reaches agreement to divest majority of Classic Brands in Australia for £172m
|
15 August 2012 |
|
GSK to acquire Human Genome Sciences for US$14.25 per share in cash
|
16 July 2012 |
|
GSK and Theravance announce regulatory submissions for FF/VI
|
15 July 2012 |